Vitamin D and gene networks in human osteoblasts

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  van de Peppel, Jeroen ^a   van Leeuwen, Johannes P T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autocrine paracrine mechanisms; Differentiation; Immune system; Mineralization; Osteoblast; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; OSTEOCALCIN; OSTEOPONTIN; PHOSPHATE; VITAMIN D; VITAMIN D RECEPTOR;

AUTOCRINE EFFECT; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; CALCIUM BALANCE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE TARGETING; HUMAN; METABOLIC REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARACRINE SIGNALING; PHOSPHATE BALANCE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84900986598     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00137     Document Type: Review

References (149)

1. Anderson, H. C. (1995). Molecular biology of matrix vesicles. Clin. Orthop. Relat. Res. 266-280. doi: 10.1097/00003086-199505000-00034
2. Anderson, H. C., Garimella, R., and Tague, S. E. (2005). The role of matrix vesicles in growth plate development and biomineralization. Front. Biosci. 10:1576. doi: 10.2741/1576
3. Anderson, P. H., Lam, N. N., Turner, A. G., Davey, R. A., Kogawa, M., Atkins, G. J., et al. (2013). The pleiotropic effects of vitamin D in bone. J. Steroid Biochem. Mol. Biol. 136, 190-194. doi: 10.1016/j.jsbmb.2012.08.008
4. 3. Bone 40, 1517-1528. doi: 10.1016/j.bone.2007.02.024
5. Atkins, G. J., and Findlay, D. M. (2012). Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int. 23, 2067-2079. doi: 10.1007/s00198-012-1915-z
6. Bilezikian, J. P., Raisz, L. G., Rodan, G. A., and Karaplis, A. C. (2002). "Embryonic development of bone and the molecular regulation of intramembranous and endochondral bone formation," in Principles of Bone Biology, ed A. C. Karaplis (San Diego, CA: Academic Press), 53-84. doi: 10.1016/B978-0-12-373884-4.00025-2
7. 3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J. Bone Miner. Res. 10, 197-204. doi: 10.1002/jbmr.5650100205
8. Bonewald, L. F. (2011). The amazing osteocyte. J. Bone Miner. Res. 26, 229-238. doi: 10.1002/jbmr.320
9. 3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267, 8943-8949.
10. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342. doi: 10.1038/nature01658
11. Bruedigam, C., Eijken, M., Koedam, M., van de Peppel, J., Drabek, K., Chiba, H., et al. (2010). A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 28, 916-927. doi: 10.1002/stem.405
12. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., et al. (2003). Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846. doi: 10.1038/nature02040
13. Chen, C. T., Shih, Y. R., Kuo, T. K., Lee, O. K., and Wei, Y. H. (2008). Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26, 960-968. doi: 10.1634/stemcells.2007-0509
14. 3 and BMP2 via two specific vitamin D receptors. J. Tissue Eng. Regen. Med. doi: 10.1002/term.1770. [Epub ahead of print].
15. Chen, K., Aenlle, K. K., Curtis, K. M., Roos, B. A., and Howard, G. A. (2012a). Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR. Bone 51, 69-77. doi: 10.1016/j.bone.2012.04.002
16. 3 inhibits osteoblastic differentiation of mouse periodontal fibroblasts. Arch. Oral Biol. 57, 453-459. doi: 10.1016/j.archoralbio.2011.10.005
17. Chow, J. W., Wilson, A. J., Chambers, T. J., and Fox, S. W. (1998). Mechanical loading stimulates bone formation by reactivation of bone lining cells in 13-Week-Old Rats. J. Bone Miner. Res. 13, 1760-1767. doi: 10.1359/jbmr.1998.13.11.1760
18. Corrado, A., Neve, A., and Cantatore, F. P. (2013). Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clin. Exp. Med. 13, 81-84. doi: 10.1007/s10238-011-0170-5
19. 3 in osteoblast differentiation. Mol. Cell. Endocrinol. 338, 84-92. doi: 10.1016/j.mce.2011.03.011
20. Dobnig, H., and Turner, R. T. (1995). Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136, 3632-3638. doi: 10.1210/en.136.8.3632
21. 3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp. Cell Res. 274, 323-333. doi: 10.1006/excr.2002.5474
22. 3 and the aging-related forkhead box O and sestrin proteins in osteoblasts. J. Steroid Biochem. Mol. Biol. 136, 112-119. doi: 10.1016/j.jsbmb.2012.09.011
23. 3-treated MC3T3-E1 cells. J. Steroid Biochem. Mol. Biol. 89-90, 405-407. doi: 10.1016/j.jsbmb.2004.03.008
24. Eijken, M., Koedam, M., van Driel, M., Buurman, C. J., Pols, H. A. P., and van Leeuwen, J. P. T. M. (2006). The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell. Endocrinol. 248, 87-93. doi: 10.1016/j.mce.2005.11.034
25. Eijken, M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., et al. (2007). The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 21, 2949-2960. doi: 10.1096/fj.07-8080com
26. Endo, H., Kiyoki, M., Kawashima, K., Naruchi, T., and Hashimoto, Y. (1980). Vitamin D3 metabolites and PTH synergistically stimulate bone formation of chick embryonic femur in vitro. Nature 286, 262-264. doi: 10.1038/286262a0
27. Erben, R. G., Weiser, H., Sinowatz, F., Rambeck, W. A., and Zucker, H. (1992). Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif. Tissue Int. 50, 228-236. doi: 10.1007/BF00296287
28. Everts, V., Delaisse, J. M., Korper, W., Jansen, D. C., Tigchelaar-Gutter, W., Saftig, P., et al. (2002). The bone lining cell: its role in cleaning lacunae and initiating bone formation. J. Bone Miner. Res. 17, 77-90. doi: 10.1359/jbmr.2002.17.1.77
29. Farach-Carson, M. C., and Xu, Y. (2002). Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells. Steroids 67, 467-470. doi: 10.1016/S0039-128X(01)00168-4
30. 3 in human osteosarcoma cells. J. Biol. Chem. 263, 18938-18945.
31. 3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the genes transcriptional start site. J. Steroid Biochem. Mol. Biol. 103, 440-445. doi: 10.1016/j.jsbmb.2006.11.018
32. Friedenstein, A. J., Deriglasova, U. F., Kulagina, N. N., Panasuk, A. F., Rudakowa, S. F., Luriá, E. A., et al. (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 2, 83-92.
33. 3 on bone remodeling. Calcif. Tissue Int. 31, 209-213. doi: 10.1007/BF02407183
34. Gardiner, E. M., Baldock, P. A., Thomas, G. P., Sims, N. A., Henderson, N. K., Hollis, B., et al. (2000). Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J. 14, 1908-1916. doi: 10.1096/fj.99-1075com
35. Geng, S., Zhou, S., and Glowacki, J. (2011a). Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase. J. Bone Miner. Res. 26, 1145-1153. doi: 10.1002/jbmr.298
36. Geng, S., Zhou, S., and Glowacki, J. (2011b). Age-related decline in osteoblastogenesis and 1α-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone. Aging Cell 10, 962-971. doi: 10.1111/j.1474-9726.2011.00735.x
37. Godschalk, M., Levy, J. R., and Downs, R. W. (1992). Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J. Bone Miner. Res. 7, 21-27. doi: 10.1002/jbmr.5650070105
38. Grundberg, E., Adoue, V., Kwan, T., Ge, B., Duan, Q. L., Lam, K. C. L., et al. (2011). Global analysis of the impact of environmental perturbation on cis-regulation of gene expression. PLoS Genet. 7:e1001279. doi: 10.1371/journal.pgen.1001279
39. Haussler, M. R., Haussler, C. A., Whitfield, G. K., Hsieh, J.-C., Thompson, P. D., Barthel, T. K., et al. (2010). The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J. Steroid Biochem. Mol. Biol. 121, 88-97. doi: 10.1016/j.jsbmb.2010.03.019
40. Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J. C., Thompson, P. D., Selznick, S. H., et al. (1998). The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13, 325-349. doi: 10.1359/jbmr.1998.13.3.325
41. 3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 39, 9181-9193. doi: 10.1093/nar/gkr654
42. Henry, H., and Norman, A. (1978). Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 201, 835-837. doi: 10.1126/science.684411
43. Hewison, M., Freeman, L., Hughes, S. V., Evans, K. N., Bland, R., Eliopoulos, A. G., et al. (2003). Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170, 5382-5390.
44. Hewison, M., Zehnder, D., Chakraverty, R., and Adams, J. S. (2004). Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Mol. Cell. Endocrinol. 215, 31-38. doi: 10.1016/j.mce.2003.11.017
45. Hicok, K. C., Thomas, T., Gori, F., Rickard, D. J., Spelsberg, T. C., and Riggs, B. L. (1998). Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J. Bone Miner. Res. 13, 205-217. doi: 10.1359/jbmr.1998.13.2.205
46. Holick, M. F. (1995). Defects in the synthesis and metabolism of vitamin D. Exp. Clin. Endocrinol. Diabetes 103, 219-227. doi: 10.1055/s-0029-1211354
47. Hong, D., Chen, H.-X., Yu, H.-Q., Liang, Y., Wang, C., Lian, Q.-Q., et al. (2010). Morphological and proteomic analysis of early stage of osteoblast differentiation in osteoblastic progenitor cells. Exp. Cell Res. 316, 2291-2300. doi: 10.1016/j.yexcr.2010.05.011
48. 3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55, 153-163. doi: 10.1046/j.1432-0436.1994.5520153.x
49. 3 (1,25D) on osteocyte like cells. J. Steroid Biochem. Mol. Biol. 136, 1-4. doi: 10.1016/j.jsbmb.2012.09.029
50. Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., and Manolagas, S. C. (1998). Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 13, 793-802. doi: 10.1359/jbmr.1998.13.5.793
51. Jørgensen, N. R., Henriksen, Z., Sørensen, O. H., and Civitelli, R. (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69, 219-226. doi: 10.1016/j.steroids.2003.12.005
52. Karunaratne, A., Esapa, C. T., Hiller, J., Boyde, A., Head, R., Bassett, J. H. D., et al. (2012). Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging. J. Bone Min. Res. 27, 876-890. doi: 10.1002/jbmr.1495
53. 3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Bone 23, 141-146. doi: 10.1016/S8756-3282(98)00085-4
54. Kawamori, Y., Katayama, Y., Asada, N., Minagawa, K., Sato, M., Okamura, A., et al. (2010). Role for vitamin D receptor in the neuronal control of the hematopoietic stem cell niche. Blood 116, 5528-5535. doi: 10.1182/blood-2010-04-279216
55. Kearns, A. E., Donohue, M. M., Sanyal, B., and Demay, M. B. (2001). Cloning and characterization of a novel protein kinase that impairs osteoblast differentiation in vitro. J. Biol. Chem. 276, 42213-42218. doi: 10.1074/jbc.M106163200
56. 3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 338, 653-661. doi: 10.1056/NEJM199803053381004
57. Komarova, S. V., Ataullakhanov, F. I., and Globus, R. K. (2000). Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am. J. Physiol. Cell Physiol. 279, C1220-C1229.
58. Koshihara, Y., and Hoshi, K. (1997). Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J. Bone Miner. Res. 12, 431-438. doi: 10.1359/jbmr.1997.12.3.431
59. Kostenuik, P. J., and Shalhoub, V. (2001). Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr. Pharm. Des. 7, 613-635. doi: 10.2174/1381612013397807
60. 3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells. Eur. J. Endocrinol. 144, 549-557. doi: 10.1530/eje.0.1440549
61. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176. doi: 10.1016/S0092-8674(00)81569-X
62. Li, J., Jin, D., Fu, S., Mei, G., Zhou, J., Lei, L., et al. (2013). Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Biochem. Biophys. Res. Commun. 436, 632-637. doi: 10.1016/j.bbrc.2013.04.111
63. Li, J. J., and Sodek, J. (1993). Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem. J. 289(Pt 3), 625-629.
64. Li, Y. C., Pirro, A. E., Amling, M., Delling, G., Baron, R., Bronson, R., et al. (1997). Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U.S.A. 94, 9831-9835. doi: 10.1073/pnas.94.18.9831
65. Lian, J. B., Shalhoub, V., Aslam, F., Frenkel, B., Green, J., Hamrah, M., et al. (1997). Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138, 2117-2127.
66. Lian, J. B., Stein, G. S., van Wijnen, A. J., Stein, J. L., Hassan, M. Q., Gaur, T., et al. (2012). MicroRNA control of bone formation and homeostasis. Nat. Revi. Endocrinol. 8, 212-227. doi: 10.1038/nrendo.2011.234
67. Lieben, L., Masuyama, R., Torrekens, S., Van Looveren, R., Schrooten, J., Baatsen, P., et al. (2012). Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced Inhibition of Bone Mineralization. J. Clin. Invest. 122, 1803-1815. doi: 10.1172/JCI45890
68. Lisse, T. S., Adams, J. S., and Hewison, M. (2013a). Vitamin D and microRNAs in bone. Crit. Rev. Eukaryot. Gene Expr. 23, 195-214. doi: 10.1615/CritRevEukaryotGeneExpr.2013007147
69. Lisse, T. S., Chun, R. F., Rieger, S., Adams, J. S., and Hewison, M. (2013b). Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. J. Bone Miner. Res. 28, 1478-1488. doi: 10.1002/jbmr.1882
70. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13, 5907-5917.
71. Mackie, E. J., Ahmed, Y. A., Tatarczuch, L., Chen, K.-S., and Mirams, M. (2008). Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol. 40, 46-62. doi: 10.1016/j.biocel.2007.06.009
72. Mackie, E. J., Tatarczuch, L., and Mirams, M. (2011). The skeleton: a multi-functional complex organ. The growth plate chondrocyte and endochondral ossification. J. Endocrinol. 211, 109-121. doi: 10.1530/JOE-11-0048
73. 3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Matrix Biol. 25, 47-58. doi: 10.1016/j.matbio.2005.09.001
74. Martinello, T., Bronzini, I., Volpin, A., Vindigni, V., Maccatrozzo, L., Caporale, G., et al. (2012). Successful recellularization of human tendon scaffolds using adipose-derived mesenchymal stem cells and collagen gel. J. Tissue Eng. Regen. Med. doi: 10.1002/term.1557. [Epub ahead of print].
75. Mathieu, C., Van Etten, E., Gysemans, C., Decallonne, B., Kato, S., Laureys, J., et al. (2001). In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 16, 2057-2065. doi: 10.1359/jbmr.2001.16.11.2057
76. Matsumoto, T., Ezawa, I., Morita, K., Kawanobe, Y., and Ogata, E. (1985). Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis. J. Nutr. Sci. Vitaminol. 31, S61-S65. doi: 10.3177/jnsv.31.Supplement_S61
77. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 12, 27-32. doi: 10.1016/8756-3282(91)90051-J
78. McCollum, E. V., Pitz, W., Simmonds, N., Becker, J. E., Shipley, P. G., and Bunting, R. W. (2002). The effect of additions of fluorine to the diet of the rat on the quality of the teeth. 1925. Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. 1922. The effect of addition. J. Biol. Chem. 277:E8.
79. 3 in intestinal cells. Mol. Endocrinol. 20, 1447-1461. doi: 10.1210/me.2006-0031
80. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2010). Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 121, 136-141. doi: 10.1016/j.jsbmb.2010.02.011
81. Minguell, J. J., Erices, A., and Conget, P. (2001). Mesenchymal stem cells. Exp. Biol. Med. (Maywood). 226, 507-520.
82. Misof, B. M., Roschger, P., Tesch, W., Baldock, P. A., Valenta, A., Messmer, P., et al. (2003). Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals. Calcif. Tissue Int. 73, 251-257. doi: 10.1007/s00223-002-2139-6
83. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., et al. (2011). Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234. doi: 10.1038/nm.2452
84. Nishimura, R., Hata, K., Ono, K., Amano, K., Takigawa, Y., Wakabayashi, M., et al. (2012). Regulation of endochondral ossification by transcription factors. Front. Biosci. 17:4076. doi: 10.2741/4076
85. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or Osteopontin) gene expression. Proc. Natl. Acad. Sci. U.S.A. 87, 9995-9999. doi: 10.1073/pnas.87.24.9995
86. 3; are both indispensable for calcium and phosphorus homeostasis. Life Sci. 27, 229-237. doi: 10.1016/0024-3205(80)90142-3
87. 3 24-hydroxylase gene. J. Biol. Chem. 269, 10545-10550.
88. Owen, T. A., Aronow, M. S., Barone, L. M., Bettencourt, B., Stein, G. S., and Lian, J. B. (1991). Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in norma. Endocrinology 128, 1496-1504. doi: 10.1210/endo-128-3-1496
89. Ozono, K., Liao, J., Kerner, S. A., Scott, R. A., and Pike, J. W. (1990). The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J. Biol. Chem. 265, 21881-21888.
90. 3 increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J. Biol. Chem. 262, 13424-13428.
91. Piek, E., Sleumer, L. S., van Someren, E. P., Heuver, L., de Haan, J. R., de Grijs, I., et al. (2010). Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone 46, 613-627. doi: 10.1016/j.bone.2009.10.024
92. Pols, H. A., Birkenhäger, J. C., Schilte, J. P., and Visser, T. J. (1988a). Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells. Biochim. Biophys. Acta 970, 122-129. doi: 10.1016/0167-4889(88)90170-X
93. 3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells. Biochem. Biophys. Res. Commun. 156, 588-594. doi: 10.1016/S0006-291X(88)80883-0
94. Prince, M., Banerjee, C., Javed, A., Green, J., Lian, J. B., Stein, G. S., et al. (2001). Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell. Biochem. 80, 424-440. doi: 10.1002/1097-4644(20010301)80:3%3C424::AID-JCB160%3E3.0.CO;2-6
95. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20, 1352-1360. doi: 10.1101/gr.107920.110
96. Reid, I. R., Bolland, M. J., and Grey, A. (2014). Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383, 146-155. doi: 10.1016/S0140-6736(13)61647-5
97. Reinhardt, T. A., and Horst, R. L. (1990). Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 127, 942-948. doi: 10.1210/endo-127-2-942
98. Sammons, J., Ahmed, N., El-Sheemy, M., and Hassan, H. T. (2004). The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev. 13, 273-280. doi: 10.1089/154732804323099208
99. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129, 3139-3146. doi: 10.1210/endo-129-6-3139
100. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res. 23, 213-229. doi: 10.3109/07435809709031855
101. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138, 3864-3872.
102. 3 levels are correlated with the healing process after chick tibial fracture. J. Bone Miner. Res. 12, 598-606. doi: 10.1359/jbmr.1997.12.4.598
103. 3 selectively induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 99, 13487-13491. doi: 10.1073/pnas.202471299
104. Shi, Y.-C., Worton, L., Esteban, L., Baldock, P., Fong, C., and Eisman, J. A. (2007). Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation. Bone 41, 87-96. doi: 10.1016/j.bone.2007.04.174
105. Shiozawa, Y., Pedersen, E. A., Havens, A. M., Jung, Y., Mishra, A., Joseph, J., et al. (2011). Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121, 1298-1312. doi: 10.1172/JCI43414
106. Siggelkow, H., Schulz, H., Kaesler, S., Benzler, K., Atkinson, M. J., and Hüfner, M. (1999). 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcif. Tissue Int. 64, 414-421. doi: 10.1007/PL00005823
107. Sims, N. A., and Martin, T. J. (2014). Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 3, 481. doi: 10.1038/bonekey.2013.215
108. Sooy, K., Sabbagh, Y., and Demay, M. B. (2004). Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro. J. Cell. Biochem. 94, 81-87. doi: 10.1002/jcb.20313
109. 3 action in osteoblast-like cells. Bone Miner. 26, 27-42. doi: 10.1016/S0169-6009(08)80160-2
110. 3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. J. Bone Miner. Res. 13, 36-43. doi: 10.1359/jbmr.1998.13.1.36
111. 3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 137, 2001-2011. doi: 10.1210/endo.137.5.8612541
112. St-Arnaud, R. (2010). CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J. Steroid Biochem. Mol. Biol. 121, 254-256. doi: 10.1016/j.jsbmb.2010.02.002
113. Tam, C. S., Heersche, J. N., Jones, G., Murray, T. M., and Rasmussen, H. (1986). The effect of vitamin D on bone in vivo. Endocrinology 118, 2217-2224. doi: 10.1210/endo-118-6-2217
114. Tarroni, P., Villa, I., Mrak, E., Zolezzi, F., Mattioli, M., Gattuso, C., et al. (2012). Microarray analysis of 1,25(OH)2D3 regulated gene expression in human primary osteoblasts. J. Cell. Biochem. 113, 640-649. doi: 10.1002/jcb.23392
115. Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., et al. (2007). Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5, 464-475. doi: 10.1016/j.cmet.2007.05.001
116. Terrand, J., Bruban, V., Zhou, L., Gong, W., El Asmar, Z., May, P., et al. (2009). LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J. Biol. Chem. 284, 381-388. doi: 10.1074/jbc.M806538200
117. Teti, A. (2011). Bone development: overview of bone cells and signaling. Curr. Osteoporos. Rep. 9, 264-273. doi: 10.1007/s11914-011-0078-8
118. Thomas, G. (2000). Species-divergent regulation of human and mouse osteocalcin genes by calciotropic hormones. Exp. Cell Res. 258, 395-402. doi: 10.1006/excr.2000.4912
119. 3 metabolites. Edited by Andrzej T Slominski. PLoS ONE 8:e75338. doi: 10.1371/journal.pone.0075338
120. Turner, A. G., Dwivedi, P. P., May, B. K., and Morris, H. A. (2007). Regulation of the CYP27B1 5'-flanking region by transforming growth factor-beta in ROS 17/2.8 osteoblast-like cells. J. Steroid Biochem. Mol. Biol. 103, 322-325. doi: 10.1016/j.jsbmb.2006.12.041
121. Ueno, K., Katayama, T., Miyamoto, T., and Koshihara, Y. (1992). Interleukin-4 enhances In vitro; mineralization in human osteoblast-like cells. Biochem. Biophys. Res. Commun. 189, 1521-1526. doi: 10.1016/0006-291X(92)90248-J
122. Van Driel, M., Koedam, M., Buurman, C. J., Hewison, M., Chiba, H., Uitterlinden, A. G., et al. (2006a). Evidence for auto/paracrine actions of vitamin D in bone: 1 -hydroxylase expression and activity in human bone cells. FASEB J. 20, 2417-2419. doi: 10.1096/fj.06-6374fje
123. 3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J. Cell. Biochem. 99, 922-935. doi: 10.1002/jcb.20875
124. Van Holten, J., Reedquist, K., Sattonet-Roche, P., Smeets, T. J. M., Plater-Zyberk, C., Vervoordeldonk, M. J., et al. (2004). Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res. Ther. 6, R239-R249. doi: 10.1186/ar1165
125. 3 Recep. Endocrinology 130, 2259-2266.
126. 3 receptor gene expression by parathyroid hormone and cAMP-agonists. Biochem. Biophys. Res. Commun. 185, 881-886. doi: 10.1016/0006-291X(92)91709-Y
127. van Leeuwen, J. P., Pols, H. A., Schilte, J. P., Visser, T. J., and Birkenhäger, J. C. (1991). Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells. Calcif. Tissue Int. 49, 35-42. doi: 10.1007/BF02555900
128. 3. J. Steroid Biochem. Mol. Biol. 136, 94-97. doi: 10.1016/j.jsbmb.2012.12.001
129. Viereck, V., Siggelkow, H., Tauber, S., Raddatz, D., Schutze, N., and Hüfner, M. (2002). Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J. Cell. Biochem. 86, 348-356. doi: 10.1002/jcb.10220
130. 3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138, 2953-2962.
131. 3 in human osteoblast-like cells. J. Bone Miner. Res. 11, 472-479. doi: 10.1002/jbmr.5650110408
132. Wang, E. A. (1993). Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends Biotechnol. 11, 379-383. doi: 10.1016/0167-7799(93)90096-R
133. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998). Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282. doi: 10.1172/JCI2799
134. Weisman, Y., Salama, R., Harell, A., and Edelstein, S. (1978). Serum 24,25-Dihydroxyvitamin D and 25-Hydroxyvitamin D Concentrations in Femoral Neck Fracture. Br. Med. J. 2, 1196. doi: 10.1136/bmj.2.6146.1196-a
135. Woeckel, V. J., Alves, R. D. A. M., Swagemakers, S. M. A., Eijken, M., Chiba, H., van der Eerden, B. C. J., et al. (2010). 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles. J. Cell. Physiol. 225, 593-600. doi: 10.1002/jcp.22244
136. 3 being dominant over interferon-β in stimulating mineralization. J. Cell. Physiol. 227, 3258-3266. doi: 10.1002/jcp.24020
137. 3 stimulates activin a production to fine-tune osteoblast-induced mineralization. J. Cell. Physiol. 228, 2167-2174. doi: 10.1002/jcp.24388
138. 3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology 147, 4801-4810. doi: 10.1210/en.2006-0403
139. Yamaguchi, M., and Weitzmann, M. N. (2012). High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. Int. J. Mol. Med. 29, 934-938. doi: 10.3892/ijmm.2012.900
140. Yamamoto, Y., Yoshizawa, T., Fukuda, T., Shirode-Fukuda, Y., Yu, T., Sekine, K., et al. (2013). Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 154, 1008-1020. doi: 10.1210/en.2012-1542
141. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., et al. (1999). Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321. doi: 10.1126/science.283.5406.1317
142. Yarram, S. J., Tasman, C., Gidley, J., Clare, M., Sandy, J. R., and Mansell, J. P. (2004). Epidermal growth factor and calcitriol synergistically induce osteoblast maturation. Mol. Cell. Endocrinol. 220, 9-20. doi: 10.1016/j.mce.2004.04.005
143. Yin, T. (2006). The stem cell niches in bone. J. Clin. Invest. 116, 1195-1201. doi: 10.1172/JCI28568
144. Yoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., et al. (1997). Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16, 391-396. doi: 10.1038/ng0897-391
145. 3 inhibits osteocalcin expression in mouse through an indirect mechanism. J. Biol. Chem. 272, 110-116. doi: 10.1074/jbc.272.1.110
146. Zhou, S., Geng, S., and Glowacki, J. (2013). Histone deacetylation mediates the rejuvenation of osteoblastogenesis by the combination of 25(OH)D3 and parathyroid hormone in MSCs from elders. J. Steroid Biochem. Mol. Biol. 136, 156-159. doi: 10.1016/j.jsbmb.2012.09.002
147. Zhou, S., Glowacki, J., Kim, S. W., Hahne, J., Geng, S., Mueller, S. M., et al. (2012). Clinical characteristics influence in vitro action of 1,25-dihydroxyvitamin D 3in human marrow stromal cells. J. Bone Miner. Res. 27, 1992-2000. doi: 10.1002/jbmr.1655
148. Zhou, S., LeBoff, M. S., and Glowacki, J. (2010). Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology 151, 14-22. doi: 10.1210/en.2009-0969
149. 3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro? Chin. Med. J. (Engl.) 119, 1278-1286.